Federal contract award

HQ085122C0001

FMS SM-3 BLK IIA ALL UP ROUNDS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeDCMA MISSILES
NAICS336414 — Guided Missile and Space Vehicle Manufacturing
PSC1410 — Guided Missiles
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST PLUS INCENTIVE FEE
Obligations$602.0M
Current contract value$615.3M
Potential contract value / ceiling$615.3M
Start dateJun 14, 2022
Current end dateDec 31, 2026
Potential end dateDec 31, 2026
Latest award activityMay 22, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 87 of 87 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 11, 2026A00019$0FY22 US AURS
May 22, 2026A00018$0FY22 US AURS
Apr 24, 2026P00034$0FMS SM-3 BLK IIA ALL UP ROUNDS
Apr 24, 2026P00034$0FY22 US AURS
Mar 31, 2026P00033$0FY22 US AURS
Mar 19, 2026A00017$0FY22 US AURS
Mar 18, 2026P00032$0SM-3 BLOCK IIA GOLDEN UNIT MAINTENANCE
Feb 9, 2026P00031$115.0KSM-3 BLOCK IIA GOLDEN UNIT MAINTENANCE
Feb 9, 2026P00031$115.0KSM-3 BLOCK IIA GOLDEN UNIT MAINTENANCE
Dec 16, 2025P00030$0FY22 US AURS
Dec 16, 2025P00030$0FY22 US AURS
Nov 10, 2025A00016$0FY22 US AURS
Sep 30, 2025P00029$0FY22 US AURS
Sep 30, 2025P00029$0FY22 US AURS
Sep 26, 2025A00014$0FY22 US AURS
Sep 26, 2025A00015$0FY22 US AURS
Sep 19, 2025A00013$0FY22 US AURS
Sep 8, 2025A00012$0FY22 US AURS
Jul 18, 2025A00011$0FY22 US AURS
Jul 14, 2025P00027$0FY22 US AURS
Jul 14, 2025P00027$0FY22 US AURS
Jul 14, 2025P00028$0FY22 US AURS
Jul 14, 2025P00028$0FY22 US AURS
Jul 2, 2025P00025$0FMS SM-3 BLK IIA ALL UP ROUNDS
Jul 2, 2025P00025$0FY22 US AURS
Jul 2, 2025P00026$0FMS SM-3 BLK IIA ALL UP ROUNDS
Jul 2, 2025P00026$0FY22 US AURS
Apr 3, 2025P00022$0FY21 FMS AURS
Apr 3, 2025P00022$0FY22 US AURS
Apr 3, 2025P00023$407.0KFY22 US AURS
Apr 3, 2025P00024$0FY22 US AURS
Apr 2, 2025P00021$0FY21 FMS AURS
Apr 2, 2025P00021$0FY22 US AURS
Mar 20, 2025P00020$0FY21 FMS AURS
Mar 20, 2025P00020$0FY22 US AURS
Dec 13, 2024P00019$0FY21 FMS AURS
Dec 13, 2024P00019$0FY22 US AURS
Nov 5, 2024A00008$0FY22 US AURS
Oct 10, 2024A00007$0FY22 US AURS
Oct 10, 2024P00018$0FY21 FMS AURS
Oct 10, 2024P00018$0FY22 US AURS
Aug 9, 2024P00017$0FY21 FMS AURS
Aug 9, 2024P00017$96.0KFY22 US AURS
Aug 8, 2024P00016$0FY21 FMS AURS
Aug 8, 2024P00016$0FY22 US AURS
Jul 25, 2024P00015$0NO FMS ACTION.
Jul 25, 2024P00015$471.0KINCREMENTALLY FUND CLIN 2016 AND UPDATE AOF, ACCORDINGLY.
Jul 22, 2024P00014$0FY21 FMS AURS
Jul 22, 2024P00014$600.8KFY22 US AURS
Jul 16, 2024P00013$0CEILING INCREASE, INCREMENTAL FUNDING, UPDATE AOF, INCREASE HOURS TO SUPPORT CEILING
Jul 16, 2024P00013$0CEILING INCREASE, HOURS INCREASE, INC FDG,AOF UPDATE
Jul 8, 2024P00012$0FY21 FMS AURS
Jul 8, 2024P00012$-489.5KFY22 US AURS
Jul 7, 2024A00010$0FY22 US AURS
May 28, 2024A00009$0FY22 US AURS
May 1, 2024P00011$0UPDATE SOW INCREASE CEILING ON CLIN 3001 AND 2016 FUND CLIN 3001 AND 2016 INCREASE CLIN 2016 HOURS UPDATE AOF ALL UPDATES ARE WITHIN THE CURRENT CONTRACT SCOPE
May 1, 2024P00011$531.7KUPDATE SOW INCREASE CEILING ON CLIN 3001 AND 2016 FUND CLIN 3001 AND 2016 INCREASE CLIN 2016 HOURS UPDATE AOF ALL UPDATES ARE WITHIN THE CURRENT CONTRACT SCOPE
Apr 18, 2024A00006$0FY22 US AURS
Mar 20, 2024P00010$0FY21 FMS AURS - PROVIDE 6 MONTHS ADDITIONAL OBSOLESCENCE MITIGATION SUPPORT AND UPDATE SOW
Mar 20, 2024P00010$1.1MFY22 US AURS - PROVIDE 6 MONTHS ADDITIONAL OBSOLESCENCE MITIGATION SUPPORT AND UPDATE SOW
Jan 30, 2024A00005$0FY22 US AURS
Dec 21, 2023P00009$0NO ACTION TO FMS CLINS.
Dec 21, 2023P00009$532.0KINCREASE CEILING ON CLIN 3001 TO APPLY INC FDG INC FUND CLIN 3001 IN THE AMOUNT OF $532K UPDATE AOF ACCORDINGLY
Dec 4, 2023P00008$0INCREASE VALUE AND INCREMENTALLY FUND
Dec 4, 2023P00008$580.8KFY22 US AURS
Dec 1, 2023A00004$0FY22 US AURS
Oct 24, 2023A00003$0FY22 US AURS
Oct 24, 2023P00007$0FUNDING FOR B&P CLIN 3001.
Oct 24, 2023P00007$180.0KFUNDING FOR B&P ON CLIN 3001.
Aug 30, 2023P00006$0FY21 FMS AURS
Aug 30, 2023P00006$489.5KFY22 US AURS
Aug 1, 2023P00005$0FY21 FMS AURS
Aug 1, 2023P00005$781.0KFY22 US AURS
Apr 20, 2023P00004$0FY21 FMS AURS - ADDING CLIN 3001 B&P AND FULLY FUNDING.
Apr 20, 2023P00004$2.0MFY22 US AURS
Apr 19, 2023P00003$9.9MFY21 FMS AURS AND FMS IOM
Apr 19, 2023P00003$-39.9MFY21 & 22 US AURS
Apr 10, 2023A00002$0FY22 US AURS
Mar 22, 2023A00001$0FY22 US AURS
Sep 27, 2022P00002$0FY21 FMS AURS
Sep 27, 2022P00002$0FY22 US AURS
Jul 29, 2022P00001$195.8MFY21 AURS FMS CASE J-AP-AUI
Jul 29, 2022P00001$0FY21 AND FY22 US AURS
Jun 14, 20220$0FMS SM-3 BLK IIA ALL UP ROUNDS
Jun 14, 20220$634.5MFY22 US AURS
Jun 14, 2022P00023$0FMS SM-3 BLK IIA ALL UP ROUNDS
Jun 14, 2022P00024$0FMS SM-3 BLK IIA ALL UP ROUNDS

Estimated positioning window

Nov 1, 2026 – Jan 30, 2027

Recompete signal:
80/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 80/100. Available recorded signals: 75 points.

Contract end 2026-12-31 (60 days from calculation)
+35 points
50 historical awards in this buyer and category group
+15 points
87 recorded award transactions
+10 points
Latest award action: 2026-05-22
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.